Close
Nordic 9Nordic 9

Gen Ilac (investor - Corporate Investor)

Turkey en.genilac.com.tr
See something wrong or missing? Let us know
Offices:Istanbul
Average round investment:807k USD
Average number per year:1.0
Distribution: 2021 (1)
Portfolio companies: Switzerland Galventa
Mostly invests in: Switzerland Switzerland (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Gen Ilac

Name Criteria
Sweden Västkusten Affärsänglar
80%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Denmark Capnova
78%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 4.8
  • Active last 12 months: Yes
Sweden PÄAB
75%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 2.6
Sweden Almi Invest
73%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
Denmark Martin Tromp Permin
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Denmark Mads Ingwar
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Finland Avohoidon Tutkimussäätiö
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Denmark Nicholas Francis
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Mike Watson
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Juan Capurro Boltendahl
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top